Pharmaceutical science to improve the human condition
Subtitle: Prix Galien 2011 : winners and finalist candidate of the Prix Galien USA Awards 2011
Series: Annals of the New York Academy of Sciences -- v. 1263; Annals of the New York Academy of Sciences -- v. 1263.
Publisher: Wiley Periodicals
Published: 2012
Place of publication: Malden, MA
Language: eng
Number of pages: 56
ISBN-13: 9781573318587
Subjects: Pharmacology; Pharmaceutical industry; Drug Discovery; Monoclonal Antibodies; Therapeutic use; Awards and Prizes; Pneumococcal Vaccines; Psoriasis; Drug therapy
Other titles: Prix Galien 2011 :; Winners and finalist candidate of the Prix Galien USA Awards 2011
Description: "This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases.."--
Notes: Caption title.

Includes bibliographical references.
Table of contents: title: Development of the IL-12/23 antagonist ustekinumab in psoriasis : past, present, and future perspectives : an update / Newman Yeilding ... [et al.]; title: Development and clinical evaluation of Prevnar 13, a 13-valent pneumococcal CRM₁₉₇ conjugate vaccine / William C. Gruber, Daniel A. Scott, and Emilio A. Emini; title: The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction / Carsten Goessl ... [et al.]; title: Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies / Ira V. Gupta and Roxanne C. Jewell.